A5051986130- Pharmaceutical Practices and Patient Outcomes
- Diabetes Management and Research
- Medication Adherence and Compliance
- Diabetes Treatment and Management
- Diabetes Management and Education
- Innovations in Medical Education
- Chronic Disease Management Strategies
- Opioid Use Disorder Treatment
- Metabolism, Diabetes, and Cancer
- Pharmacy and Medical Practices
- Pancreatic function and diabetes
- Pharmaceutical studies and practices
- Pain Mechanisms and Treatments
- Pain Management and Opioid Use
- Complementary and Alternative Medicine Studies
- Retinal Diseases and Treatments
- Pharmacology and Obesity Treatment
- Antibiotic Use and Resistance
- Pharmacological Effects and Toxicity Studies
- Diabetes and associated disorders
- Health Systems, Economic Evaluations, Quality of Life
- Health Sciences Research and Education
- Healthcare professionals’ stress and burnout
- Treatment of Major Depression
- Neural and Behavioral Psychology Studies
University of California, San Diego
2015-2025
VA San Diego Healthcare System
2012-2024
University of Montana
2010-2024
University of California, San Francisco
2012
Naval Medical Center San Diego
2006
<h3>Background</h3> Reports of gabapentin use in diabetic peripheral neuropathy pain stimulate a need for controlled trials to determine its comparative efficacy the therapeutic standard amitriptyline hydrochloride. <h3>Objective</h3> To compared with treating pain. <h3>Design</h3> Prospective, randomized, double-blind, double-dummy, crossover study. <h3>Setting</h3> Veterans Affairs San Diego Healthcare System, Ambulatory Care Clinic. <h3>Patients</h3> Twenty-eight veterans were referred by...
<b>Objective.</b> To examine perceived stress, coping strategies, and health-related quality of life in Doctor Pharmacy students across the first three years (pre-clinical portion) curriculum. <b>Methods.</b> Three instruments, Perceived Stress Scale, Brief COPE, Short Form-36, were administered to times a year over five-year period. Median annual scores compared using Skillings-Mack tests correlations assessed Spearman correlation. <b>Results.</b> One hundred forty-five (approximately 46%...
The goal of insulin therapy in patients with either type 1 diabetes mellitus (T1DM) or 2 (T2DM) is to match as closely possible normal physiologic secretion control fasting and postprandial plasma glucose. Modifications the molecule have resulted two long-acting analogs (glargine detemir) three rapid-acting insulins (aspart, lispro, glulisine) improved pharmacokinetic/pharmacodynamic (PK/PD) profiles. These agents can be used together basal-bolus more mimic patterns.This study reviews...
In recent years waterpipe smoking has become a popular practice amongst young adults in eastern Mediterranean countries, including Iran. The aim of this study was to assess perceptions and practices among first-year health sciences university students Iran identify factors associated with the initiation maintenance use population. Out 371 surveyed, 358 eight completed self-administered questionnaire classrooms describing their towards smoking. Two hundred ninety six responders met inclusion...
In 2012 U.S. diabetes costs were estimated to be $245 billion, with $176 billion related direct treatment and associated complications. Although a few studies have reported positive glycemic economic benefits for patients treated under primary care physician (PCP)-pharmacist collaborative practice models, no evaluated the cost-effectiveness of an endocrinologist-pharmacist model treating complex versus usual PCP similar patients.To estimate cost benefit Diabetes Intense Medical Management...
With diabetes reaching epidemic proportions globally, it is imperative to increase the number of providers equipped screen, educate, and help patients achieve glycemic control. This study evaluated long-term results student pharmacists attending a first-year Diabetes Self-Care Education Program (DSEP) by measuring knowledge retention, confidence, clinical applicability skills learned over time. The DSEP, integrated into early pharmacy curriculum, 9-h training program made up interactive...
The development and outcomes of two pharmacist-managed diabetes care clinics (DCCs) are described.Retrospective data analysis was performed to determine the for patients with type 2 mellitus who were treated in DCCs. Primary outcome measures included changes glycosylated hemoglobin (HbA(1c)), fasting plasma glucose, body mass index, low-density-lipoprotein (LDL) cholesterol, high-density-lipoprotein triglycerides, blood pressure documented annual retinal micro-albumin screening. Secondary...
Background: No previous studies exist examining the impact of a short-term pharmacist-endocrinologist collaborative practice model on glycemic control in complex patients. Objective: Evaluate outcomes associated with PharmD-Endocrinologist Diabetes Intense Medical Management (DIMM) “tune up” clinic for Methods: A retrospective cohort study 99 patients referred to DIMM versus comparator group 56 primary care provider (PCP) meeting same criteria (adult type 2 diabetes patients, glycosylated...
Glucagon-like peptide (GLP)-1 agonists are one of the newer classes medications for use in type 2 diabetes. There currently three GLP-1 on market: exenatide twice daily, liraglutide, and extended release (ER). Exenatide ER is a new weekly formulation exenatide. reduces glycosylated hemoglobin by 1.6%, with fewer gastrointestinal side effects compared twice-daily Like other agonists, can be used combination metformin, sulfonylureas, or thiazolidinediones. Patients should assessed risk...
Naltrexone is effective in treating opioid dependence by blocking µ, κ and δ opiate receptors. mainly metabolized to an active metabolite 6β-naltrexol dihydrodiol dehydrogenase enzymes. Concomitant opioids will not be while patients are taking this antagonist. This was a retrospective analysis of urinary excretion data collected from being treated with pain between November 2011 May 2012. Naltrexone, concomitant concentrations were measured liquid chromatography–tandem mass spectrometry....
Published studies assessing specific methods that patients with diabetes and their caregivers perceive as helpful means of increasing medication adherence are lacking.To determine have used to improve adherence, investigate the perceived helpfulness these methods, identify motivating factors characteristics may positively influence adherence.A cross-sectional survey was distributed at 11th annual Taking Control Your Diabetes conference in October 2005 San Diego Convention Center. Outcome...
Objective. To evaluate the effect of providing educational video podcasts to first-year pharmacy students enrolled in a self-taught pharmaceutical calculations module.Methods. Six were designed and posted online for review prior taking quizzes over course one year. The demonstrated how solve most difficult problems on each six quizzes. Quiz performance was compared 2017-2018 year (no videos available) 2018-2019 (videos available). Students provided feedback about year-end survey.Results....
The scope of pharmacy practice has evolved over the last few decades to focus on optimization medication therapy. Despite this positive impact, lack reimbursement remains a significant barrier implementation innovative pharmacist models.We describe successful development, and outcomes three types collaborative care models: (1) with physician oversight, (2) pharmacist-interprofessional teams (3) physician-pharmacist teams. outcome measurement these models varied from design phase patient...
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are novel oral anti-hyperglycemic drugs that demonstrate cardiovascular and metabolic benefits for patients with type diabetes (T2D), heart failure (HF), chronic kidney disease (CKD). There is limited knowledge of real-world data to predict adherence SGLT-2i in an ambulatory setting. The study aims T2D and/or HF CKD by building a prediction model using electronic prescription claims presented within EPIC datasets. This retrospective 174...
Abstract Objectives To evaluate the association between number of mental health conditions among individuals with type 2 diabetes (T2D) and healthcare expenditures in USA. Methods A cross-sectional study was conducted to relationship multiple (0, 1, or more conditions) T2D on using data from 2019 US Medical Expenditure Panel Survey. Key findings total 24,091,931 weighted were included for analysis; 76.8% had no co-occurring conditions, 15.5% one condition, 7.7% two conditions. Individuals...
Key Points Using data on veterans with type 2 diabetes (T2D), we evaluated the clinical end points of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) in preserving kidney function over a 3-year period. Veterans T2D initiated an SGLT2i experienced 35% reduced hazard composite endpoint compared GLP-1RA. Further research combination therapy GLP-1RA is warranted to better understand potential CKD guideline-directed medical therapy....